Question 1

What is LOPJLB’s current signal on RNAC?

Accepted Answer

LOPJLB’s latest quantitative signal on Cartesian Therapeutics, Inc. (RNAC) is BUY in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is RNAC in?

Accepted Answer

Cartesian Therapeutics, Inc. (RNAC) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Cartesian Therapeutics, Inc. (RNAC) do?

Accepted Answer

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The companyâs lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune dis…

Question 4

Where is Cartesian Therapeutics, Inc. based / listed?

Accepted Answer

Cartesian Therapeutics, Inc. is based in US, listed on NASDAQ.

Cartesian Therapeutics, Inc. (RNAC)

Key stats

Industry peers

Prediction markets

EARNINGS HISTORY

Company news